An ad hoc committee will plan and host a 1.5-day public workshop that will feature invited presentations and panel discussions. Workshop participants will examine the rationale and potential for integrating clinical trials for pets with naturally occurring cancer into translational cancer research and drug development.
Participants will be invited to discuss topics that may include
- An overview of the limitations of current preclinical oncology models and resulting late-stage drug development failures and costs;
- Strategies to support the incorporation of data from clinical trials for pets with cancer in drug development pathways;
- Gaps in the evidence base to support integration of such trials in the drug development continuum and ways to address those gaps;
- Challenges and potential solutions to greater integration of such trials in cancer drug development pathways; and
- Opportunities for further collaborations and information exchange between human and veterinary oncologists.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. An individually authored workshop summary of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
This page intentionally left blank.